MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Injections of incobotulinumtoxinA at intervals less than 10 weeks are effective and safe for cervical dystonia patients with inadequate benefit from standard injection intervals

    C. Comella, R. Hauser, S. Isaacson, D. Truong, O. Oguh, J. Hui, E. Molho, M. Brodsky, E. Furr-Stimming, G. Comes, M. Hast, D. Charles (New Philadelphia, USA)

    Objective: To compare efficacy and safety of two injection schedules of incobotulinumtoxinA for treating cervical dystonia (CD). Background: In clinical practice, some CD patients receiving…
  • MDS Virtual Congress 2021

    Cluster headache associated with secondary unilateral blepharospasm : A Case Report

    P. Dugani, A. Mehta, P. R, M. Javali, P. Acharya, R. Srinivasa (Bengaluru, India)

    Objective: We describe a case of a 31 year old lady with cluster headache associated with secondary unilateral spasm of left eyelid resulting in closure…
  • MDS Virtual Congress 2021

    A Double Blind, Placebo Controlled, Crossover Study of Incobotulinumtoxin-A in Musician’s Focal Hand Dystonia

    S. Frucht, A. Nmashie, MC. George, C. Wu, A. Pantelyat, E. Altenmüller, M. Chen, D. Feng, DM. Simpson (New York, USA)

    Objective: To determine the safety and efficacy of incobotulinumtoxin-A (BoNT) in musician’s dystonia. Background: Few published trials of BoNT in upper limb task-specific dystonia are…
  • MDS Virtual Congress 2021

    A Phase 3 Trial Evaluating the Efficacy, Duration of Effect, and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Cervical Dystonia

    J. Jankovic, C. Comella, R. Hauser, A. Patel, T. Gross, R. Rubio, D. Vitarella (Houston, USA)

    Objective: To evaluate the efficacy and safety of two doses of DaxibotulinumtoxinA for Injection (DAXI) vs placebo for treatment of cervical dystonia (CD). Background: DAXI…
  • MDS Virtual Congress 2021

    Current perspectives on the management of cervical dystonia among global clinicians

    H. Jinnah, H. Ferraz, S. Standal, P. Fattahi, A. Zuzek, N. Alibhai, K. Merath (Atlanta, USA)

    Objective: The aim of this study was to gain the perspectives of clinicians who treat patients with CD in terms of assessment and treatment goals,…
  • MDS Virtual Congress 2021

    Improvement of non-motor symptoms and quality of life after DBS stimulation for refractory dystonia: a one-year follow-up

    C. Listik, R. Cury, S. Casagrande, E. Listik, D. Arnaut, N. Santiago, J. Machado, J. de Almeida, E. Barbosa, M. Teixeira, D. de Andrade (Sao Paulo, Brazil)

    Objective: To describe the non-motor symptoms (NMS) after Deep Brain Stimulation (DBS) surgery for refractory generalized inherited/idiopathic dystonia in a prospective study. Background: DBS is…
  • MDS Virtual Congress 2021

    Pain and symptom management in a case of cervical dystonia with comorbid generalized joint hypermobility using prolotherapy with osteopathic manipulative medicine

    J. Mancini, D. Whitfield (Old Westbury, USA)

    Objective: To improve pain and quality of life in cervical dystonia (CD) with comorbid generalized joint hypermobility (GJH) using prolotherapy with osteopathic manipulative medicine (OMM).…
  • MDS Virtual Congress 2021

    COMPARISON OF ELECTROPHYSIOLOGIC AND ULTRASOUND GUIDANCE FOR ONABOTULINUM TOXIN-A INJECTIONS IN FOCAL UPPER EXTREMITY SPASTICITY AND DYSTONIA

    C. Lungu, A. Nmashie, MC. George, T. Wu, S. Shin, B. Karp, E. Considine, W. Tse, S. Frucht, C. Wu, V. Koo, G. Norato, K. Alter, M. Hallet, DM. Simpson ()

    Objective: To investigate two targeting techniques for onabotulinum toxin-A (BoNT) injection for the treatment of focal hand dystonia and upper limb spasticity: guidance with electrical…
  • MDS Virtual Congress 2021

    Approaching the lateral pterygoid muscle in botulinum toxin injections. How to avoid the maxillary artery

    S. Unal, T. Karaarslan-Turk, C. Akbostanci, E. Peker, R. Yilmaz (Ankara, Turkey)

    Objective: To investigate the course of the maxillary artery (MA) in relation to the lateral pterygoid muscle (LPM) in the Turkish population and to help…
  • MDS Virtual Congress 2021

    A National Data-Linkage Study of Incidence and Prevalence of Primary Dystonia

    G. Bailey, A. Rawlings, W. Pickrell, K. Peall (Cardiff, United Kingdom)

    Objective: To determine the nationwide prevalence and incidence rates of primary dystonia in Wales. Background: The true prevalence and incidence of dystonia remains largely unknown…
  • « Previous Page
  • 1
  • …
  • 706
  • 707
  • 708
  • 709
  • 710
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley